Pharmacology
 |
|
26 june 2019 19:00:17 |
| [ASAP] p53-Bad: A Novel Tumor Suppressor/Proapoptotic Factor Hybrid Directed to the Mitochondria for Ovarian Cancer Gene Therapy (Molecular Pharmaceutics) |
|
Tweet Molecular PharmaceuticsDOI: 10.1021/acs.molpharmaceut.9b00136
|
| 65 viewsCategory: Pharmacology |
 [ASAP] Application of Advanced Microscopic Methods to Study the Interaction of Carboxylated Fluorescent Nanodiamonds with Membrane Structures in THP-1 Cells: Activation of Inflammasome NLRP3 as the Result of Lysosome Destabilization (Molecular Pharmaceutics)RIOK2: straddling the kinase/ATPase line (Nature Reviews Drug Discovery) 
|
| blog comments powered by Disqus |
MyJournals.org
The latest issues of all your favorite science journals on one page
The latest issues of all your favorite science journals on one page
